These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Kay DM; Kramer P; Higgins D; Zabetian CP; Payami H Mov Disord; 2005 Aug; 20(8):1077-8. PubMed ID: 16001413 [No Abstract] [Full Text] [Related]
3. Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease. Pankratz N; Pauciulo MW; Elsaesser VE; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T; Nichols WC; Mov Disord; 2006 Dec; 21(12):2257-60. PubMed ID: 17078063 [TBL] [Abstract][Full Text] [Related]
4. LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease. Elbaz A Lancet Neurol; 2008 Jul; 7(7):562-4. PubMed ID: 18539536 [No Abstract] [Full Text] [Related]
5. The G2019S LRRK2 mutation: another morbid burden for Ashkenazi Jews may provide new insights on sporadic Parkinson's disease. Melamed E Mov Disord; 2013 Dec; 28(14):1912-4. PubMed ID: 24307480 [No Abstract] [Full Text] [Related]
6. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Bras JM; Guerreiro RJ; Ribeiro MH; Januario C; Morgadinho A; Oliveira CR; Cunha L; Hardy J; Singleton A Mov Disord; 2005 Dec; 20(12):1653-5. PubMed ID: 16149095 [TBL] [Abstract][Full Text] [Related]
7. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease. Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562 [TBL] [Abstract][Full Text] [Related]
15. Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease. Shanker V; Groves M; Heiman G; Palmese C; Saunders-Pullman R; Ozelius L; Raymond D; Bressman S Mov Disord; 2011 Aug; 26(10):1875-80. PubMed ID: 21611978 [TBL] [Abstract][Full Text] [Related]
16. MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease. White LR; Toft M; Kvam SN; Farrer MJ; Aasly JO J Neurosci Res; 2007 May; 85(6):1288-94. PubMed ID: 17385669 [TBL] [Abstract][Full Text] [Related]
17. LRRK2: both a cause and a risk factor for Parkinson disease? Foroud T Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895 [No Abstract] [Full Text] [Related]
19. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Tan EK; Shen H; Tan LC; Farrer M; Yew K; Chua E; Jamora RD; Puvan K; Puong KY; Zhao Y; Pavanni R; Wong MC; Yih Y; Skipper L; Liu JJ Neurosci Lett; 2005 Aug; 384(3):327-9. PubMed ID: 15955629 [TBL] [Abstract][Full Text] [Related]
20. The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: phenotype in monozygotic twins. Munhoz RP; Wakutani Y; Marras C; Teive HA; Raskin S; Werneck LC; Moreno D; Sato C; Lang AE; Rogaeva E Mov Disord; 2008 Jan; 23(2):290-4. PubMed ID: 17999435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]